Breast cancer stage at diagnosis: Caucasians versus Afro-Americans Arlene J. Zaloznik Report Pages: 195 - 198
Influence of n-3 fatty acids on the growth of human breast cancer cellsin vitro: Relationship to peroxides and Vitamin-E Véronique ChajèsWolfgang SattlerGert M. Kostner Report Pages: 199 - 212
Cutaneous side effects in breast cancer patients treated with cytostatic polychemotherapy and rh GM-CSF: Immune phenomena or drug toxicity? Gottfried J. LockerIngrid SimonitschGünther G. Steger Report Pages: 213 - 219
Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods A. MolinoR. MiccioloG. L. Cetto Report Pages: 221 - 228
Vasopressin gene related products are markers of human breast cancer William G. NorthSara PaiVincent Memoli Report Pages: 229 - 235
Biological and clinical evaluation of Lanreotide (BIM 23014), a somatostatin analogue, in the treatment of advanced breast cancer Angelo Di LeoLeonardo FerrariAldo Bono Report Pages: 237 - 244
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer Peter L. DevineMaree A. DurouxClifford W. Pollard Report Pages: 245 - 251
Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer J. Dirk IglehartBillie-Jo KernsJeffrey R. Marks Report Pages: 253 - 263
Relationship of growth stimulated by lithium, estradiol, and EGF to phospholipase C activity in MCF-7 human breast cancer cells Julia A. TaylorLeigh H. GradyWade V. Welshons Report Pages: 265 - 277
Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients Wolfram JägerWilli Sauerbrei Report Pages: 279 - 287